Product Reports Resources Pricing Login Book a demo

Provivi

Food · Santa Monica, United States · Founded 2013

A groundbreaking science-based company creating scalable, safer insect control technology that will improve the quality of life for all humans and our world MoreLess

Provivi operates in the agricultural chemicals sector, providing farmers with alternatives to traditional insecticides. The company was founded in 2013 by Dr. Pedro Coelho, Dr. Peter Meinhold, and 2018 Nobel laureate in Chemistry, Dr. Frances Arnold. Dr. Arnold, a professor at Caltech, pioneered methods of directed evolution to create new proteins. Dr. Coelho holds a Ph.D. in Chemistry from Caltech and a Master's from the University of Oxford, with a career focused on developing pheromone-based pest control solutions.

The core of Provivi's business is the development and production of insect pheromones for mating disruption. This preventative method uses dispensers that release species-specific pheromones into a field, which confuses male insects and disrupts their ability to find mates, thereby reducing the pest population in the next generation. This approach avoids harming non-target organisms, including beneficial insects and pollinators. The company's technology, based on biocatalysis and fermentation, is designed to significantly lower the manufacturing cost of pheromones, making them economically viable for large-scale row crops like corn, rice, and soy.

Provivi's product line, under names like Pheron®, includes solutions targeting major agricultural pests such as the Fall Armyworm and the Yellow Stem Borer. Products like "Provivi FAW™" and "Pherogen® Granulo FAW" have received regulatory approval in markets including Mexico and Brazil. The company offers its products in various formulations, such as dispensers for smaller farms and liquid sprays for application with existing farm equipment on larger operations. Its business model involves both direct-to-farmer sales and strategic partnerships with major agricultural companies like Syngenta and Godrej Agrovet for distribution and commercialization in global markets, including Indonesia, India, and Mexico.

Since its inception, Provivi has raised over $230 million in funding across multiple rounds. Key investors include the Gates Foundation, BASF Venture Capital, Kairos Ventures, and Temasek. This capital has supported product development, regulatory approvals, and commercial launches. For instance, a 2022 pilot program in Guanajuato, Mexico, demonstrated the effectiveness of its mating disruption technique on corn crops. After its first commercial year in Mexico, the company reported serving over 1,000 growers across 100,000 hectares. Keywords: agricultural biotechnology, crop protection, pheromones, mating disruption, integrated pest management, sustainable agriculture, insect control, agtech, biocontrol, Fall Armyworm, Yellow Stem Borer, biocatalysis, fermentation, Pheron, Provivi FAW, Syngenta partnership, agricultural chemicals, pest management solutions, crop science, non-toxic pesticides

Company overview

Provivi company information

The essential company record, classifications and operating signals in one place.

Status
Operational
Founded
2013
Headquarters
Santa Monica, United States
Employees
84
Open positions
None listed
Dealroom signal
64.5
sub industryAgriTechbusiness modelManufacturingsectorBiotechnologysectorPest ControlsectorBiopesticidessectorChemicalsectorSynthetic BiologysectorSpinoutsectorDT and LSsectorscience-basedindustryFoodclient focusb2btechnologyDeep Tech

Valuation & funding

Provivi funding history

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
CONVERTIBLEOther financing Oct 2021 $0 Undisclosed
SERIES COther financing Feb 2021 $10M $228M Bill & Melinda Gates Foundation
SERIES COther financing Dec 2020 $46M $182M Temasek · Pontifax AgTech · Spruce Capital Partners · Vivo Capital
SERIES COther financing Oct 2019 $85M $340M Spruce Capital Partners · Kairos Ventures · Tybourne Capital Management · Temasek
SERIES BOther financing Nov 2017 $21M $84M DuPont · Kairos Ventures · Kairos · Spruce Capital Partners
GRANTOther financing Feb 2016 US National Science Foundation
SERIES AOther financing Sep 2015 Kairos Ventures
EARLY VCOther financing Mar 2015 Undisclosed
SPINOUTOther financing Jan 2013 Massachusetts Institute of Technology · Caltech, California Institute of Technology
Showing 9 recorded eventsUnlock the complete deal history →

Growth signals

Provivi website traffic

Latest recorded traffic for Provivi is 2.3K monthly website visits, up 15% over the last three months. Provivi's team declined 1.2% over the past year.

Latest monthly visits2.3K 3-month web change+15% 1-year team growth-1.2%
Monthly website visits108 observations · Jul 2017–Jul 2026
Hover or focus a point to see its exact monthly valueCompare with peers →

Comparisons

Provivi compared with similar companies

Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.

Showing 8 of the closest matchesCompare every metric →

Talent graph

Provivi's talent

Book a demo to see the people
Team profiled 10 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 4 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

12 investors on Provivi's cap table

Sourced from Dealroom's funding and investor records. Investor profile links are shown where available.

Seed 1 investor entered at this stage
US National Science Foundation
Series A 4 investors entered at this stage
Kairos Ventures
Spruce Capital Partners
DuPont
Kairos
Series B+ 5 investors entered at this stage
Temasek
Pontifax AgTech
Tybourne Capital Management
Vivo Capital
Bill & Melinda Gates Foundation
Other known 2 additional known investors
Caltech, California Institute of Technology
Massachusetts Institute of Technology

Global footprint

Where Provivi has talent and traffic

Workforce by country
7 countries with
team presence
🇺🇸 United States53.1%
🇲🇽 Mexico18.4%
🇮🇩 Indonesia12.2%
🇧🇷 Brazil10.2%
🇹🇭 Thailand2%
Top 5 of 7 shown

In the news

Latest news about Provivi

Recent press, funding announcements, and product moves mentioning Provivi — open to read from the original sources.

See all news

Market sentiment

What the market is saying about Provivi

An AI-synthesized read of the highest-engagement posts about Provivi on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Provivi’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.